SCHEMBL5795561

SCHEMBL5795561

O=c1[nH]c(=S)[nH]nc1CCc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.73
▸ HPGD P15428 3/20 0.73
▸ CYP2C9 P11712 2/20 0.73
▸ PARP1 P09874 2/20 0.54
▸ DAO P14920 7/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ AR P10275 1/20 0.45
▸ MAPT P10636 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17285573 0.85 ALDH1A1 (1.00) ALDH1A1HPGDCYP2C9PARP1DAO
SCHEMBL17285533 0.73 ALDH1A1 (0.61) ALDH1A1HPGDCYP2C9HTTMAPT
SCHEMBL5791378 0.72 ALDH1A1 (1.00) ALDH1A1HPGDCYP2C9PARP1HTT
SCHEMBL7874800 0.70 HPGD (0.75) ALDH1A1HPGDCYP2C9PARP1DAO
SCHEMBL17285587 0.70 ALDH1A1 (0.57) ALDH1A1HPGDCYP2C9HTTMAPT
SCHEMBL11458310 0.70 DAO (0.50) ALDH1A1HPGDCYP2C9DAONPC1
SCHEMBL400710 0.70 ALDH1A1 (0.55) ALDH1A1HPGDCYP2C9PARP1AR
SCHEMBL1249876 0.70 PARP1 (1.00) PARP1
SCHEMBL400160 0.70 ALDH1A1 (0.55) ALDH1A1HPGDCYP2C9PARP1HTT
SCHEMBL6320498 0.69 ALDH1A1 (0.56) ALDH1A1HPGDCYP2C9HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644353-A1 AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES Bayer HealthCare AG (DE) 2006-04-12 — — EP disclosed
WO-2005003118-A1 AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES BAYER HEALTHCARE AG (DE) 2005-01-13 — — WO disclosed
Send feedback